Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02525276Unknown
Randomised, open-label trial in metabolic syndrome (4 arms), sponsored by Rigshospitalet. Primary endpoint: Insulin sensitivity at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02525276.